Tacrolimus ointment

Closed Solicitation Posted

This opportunity was awarded. See its 2 award notices in the notice history.

Solicitation number
SPE2D217R0024
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

Tacrolimus Ointment

Update #1 ·

Tacrolimus 0.03% and 0.1% ointment 30MG, 60MG AND 100MG tubes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

Files

File Type Posted
SPE2D218D0056P00001_SIGNED.pdf PDF
SPE2D218D0056_Tacrolimus_signed_award.pdf PDF
SPE2D2-17-R-0024_AMENDMENT_00002.pdf PDF
SPE2D217R0024_0001.pdf PDF
Tacrolimus_Solicitation__SPE2D217R0024.docx DOCX document

Notice history

Notice Type Posted
Tacrolimus ointment Latest Award Notice
Tacrolimus ointment Latest special notice Special Notice
Tacrolimus ointment Award Notice
This notice Original Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity